BACKGROUND: Little is known about the influence of antiretroviral therapy with or without micronutrient supplementation on the micronutrient concentrations of HIV-infected lactating women in resource-constrained settings. OBJECTIVE: We examined associations of highly active antiretroviral therapy (HAART) and lipid-based nutrient supplements (LNS) with concentrations of selected micronutrients in HIV-infected Malawian women at 24 wk postpartum. METHODS:Plasma micronutrient concentrations were measured in a subsample (n = 690) of Breastfeeding, Antiretrovirals, and Nutrition (BAN) study participants who were randomly assigned at delivery to receiveHAART, LNS, HAART+LNS, or no HAART/no LNS (control). HAART consisted of protease inhibitor-based triple therapy. LNS (140 g/d) met energy and micronutrient requirements of lactation. Multivariable linear regression tested the association of HAART and LNS, plus their interaction, with micronutrient concentrations, controlling for season, baseline viral load, and baseline CD4 count. RESULTS: We found significant HAART by LNS interactions for folate (P = 0.051), vitamin B-12 (P < 0.001), and transferrin receptors (TfRs) (P = 0.085). HAART was associated with lower folate (with LNS: -27%, P < 0.001; without LNS: -12%, P = 0.040) and higher TfR concentrations (with LNS: +14%, P = 0.004; without LNS: +28%, P < 0.001), indicating iron deficiency. LNS increased folate (with HAART: +17%, P = 0.037; without HAART: +39%, P < 0.001) and decreased TfR concentrations (with HAART only: -12%, P = 0.023). HAART was associated with lower vitamin B-12 concentrations only when LNS was present (-18%, P = 0.001), whereas LNS increased vitamin B-12 only when no HAART was present (+27%, P < 0.001). HAART, but not LNS, was associated with higher retinol-binding protein (RBP; +10%, P = 0.007). We detected no association of HAART or LNS with selenium, ferritin, or hemoglobin. CONCLUSION: The association of HAART with lower folate, iron deficiency, and higher RBP plus the attenuation of LNS effects on folate and vitamin B-12 when combined with HAART has implications for the health of lactating HIV-infected women taking HAART in prevention of mother-to-child transmission programs. This trial was registered at clinicaltrials.gov as NCT00164736.
RCT Entities:
BACKGROUND: Little is known about the influence of antiretroviral therapy with or without micronutrient supplementation on the micronutrient concentrations of HIV-infected lactating women in resource-constrained settings. OBJECTIVE: We examined associations of highly active antiretroviral therapy (HAART) and lipid-based nutrient supplements (LNS) with concentrations of selected micronutrients in HIV-infected Malawianwomen at 24 wk postpartum. METHODS: Plasma micronutrient concentrations were measured in a subsample (n = 690) of Breastfeeding, Antiretrovirals, and Nutrition (BAN) study participants who were randomly assigned at delivery to receive HAART, LNS, HAART+LNS, or no HAART/no LNS (control). HAART consisted of protease inhibitor-based triple therapy. LNS (140 g/d) met energy and micronutrient requirements of lactation. Multivariable linear regression tested the association of HAART and LNS, plus their interaction, with micronutrient concentrations, controlling for season, baseline viral load, and baseline CD4 count. RESULTS: We found significant HAART by LNS interactions for folate (P = 0.051), vitamin B-12 (P < 0.001), and transferrin receptors (TfRs) (P = 0.085). HAART was associated with lower folate (with LNS: -27%, P < 0.001; without LNS: -12%, P = 0.040) and higher TfR concentrations (with LNS: +14%, P = 0.004; without LNS: +28%, P < 0.001), indicating iron deficiency. LNS increased folate (with HAART: +17%, P = 0.037; without HAART: +39%, P < 0.001) and decreased TfR concentrations (with HAART only: -12%, P = 0.023). HAART was associated with lower vitamin B-12 concentrations only when LNS was present (-18%, P = 0.001), whereas LNS increased vitamin B-12 only when no HAART was present (+27%, P < 0.001). HAART, but not LNS, was associated with higher retinol-binding protein (RBP; +10%, P = 0.007). We detected no association of HAART or LNS with selenium, ferritin, or hemoglobin. CONCLUSION: The association of HAART with lower folate, iron deficiency, and higher RBP plus the attenuation of LNS effects on folate and vitamin B-12 when combined with HAART has implications for the health of lactating HIV-infectedwomen taking HAART in prevention of mother-to-child transmission programs. This trial was registered at clinicaltrials.gov as NCT00164736.
Authors: Valerie L Flax; Margaret E Bentley; Charles S Chasela; Dumbani Kayira; Michael G Hudgens; Rodney J Knight; Alice Soko; Denise J Jamieson; Charles M van der Horst; Linda S Adair Journal: J Nutr Date: 2012-05-30 Impact factor: 4.798
Authors: Charles S Chasela; Michael G Hudgens; Denise J Jamieson; Dumbani Kayira; Mina C Hosseinipour; Athena P Kourtis; Francis Martinson; Gerald Tegha; Rodney J Knight; Yusuf I Ahmed; Deborah D Kamwendo; Irving F Hoffman; Sascha R Ellington; Zebrone Kacheche; Alice Soko; Jeffrey B Wiener; Susan A Fiscus; Peter Kazembe; Innocent A Mofolo; Maggie Chigwenembe; Dorothy S Sichali; Charles M van der Horst Journal: N Engl J Med Date: 2010-06-17 Impact factor: 91.245
Authors: Rafael Deminice; Helena S Vassimon; Alcyone A Machado; Francisco J A de Paula; Jacqueline P Monteiro; Alceu A Jordao Journal: Nutrition Date: 2013-09-14 Impact factor: 4.008
Authors: Margo N Woods; Alice M Tang; Janet Forrester; Clara Jones; Kristy Hendricks; Bei Ding; Tamsin A Knox Journal: Clin Infect Dis Date: 2003 Impact factor: 9.079
Authors: Roland Kupka; Gernard I Msamanga; Ferdinand Mugusi; Paul Petraro; David J Hunter; Wafaie W Fawzi Journal: J Nutr Date: 2007-10 Impact factor: 4.798
Authors: Wafaie W Fawzi; Gernard I Msamanga; David Hunter; Boris Renjifo; Gretchen Antelman; Heejung Bang; Karim Manji; Saidi Kapiga; Davis Mwakagile; Max Essex; Donna Spiegelman Journal: AIDS Date: 2002-09-27 Impact factor: 4.177
Authors: C Allavena; C Delpierre; L Cuzin; D Rey; N Viget; J Bernard; P Guillot; C Duvivier; E Billaud; F Raffi Journal: J Antimicrob Chemother Date: 2012-05-15 Impact factor: 5.790
Authors: Fiona P Havers; Barbara Detrick; Sandra W Cardoso; Sima Berendes; Javier R Lama; Patcharaphan Sugandhavesa; Noluthando H Mwelase; Thomas B Campbell; Amita Gupta Journal: PLoS One Date: 2014-04-21 Impact factor: 3.240
Authors: Lindsay H Allen; Joshua W Miller; Lisette de Groot; Irwin H Rosenberg; A David Smith; Helga Refsum; Daniel J Raiten Journal: J Nutr Date: 2018-12-01 Impact factor: 4.798
Authors: Elizabeth M Widen; Shalean M Collins; Hijab Khan; Claire Biribawa; Daniel Acidri; Winifred Achoko; Harriet Achola; Shibani Ghosh; Jeffrey K Griffiths; Sera L Young Journal: Am J Clin Nutr Date: 2017-01-04 Impact factor: 7.045
Authors: Stephanie M Patton; Quan Wang; Todd Hulgan; James R Connor; Peilin Jia; Zhongming Zhao; Scott L Letendre; Ronald J Ellis; William S Bush; David C Samuels; Donald R Franklin; Harpreet Kaur; Jennifer Iudicello; Igor Grant; Asha R Kallianpur Journal: Fluids Barriers CNS Date: 2017-04-21
Authors: Daniela Hampel; Setareh Shahab-Ferdows; Erik Gertz; Valerie L Flax; Linda S Adair; Margaret E Bentley; Denise J Jamieson; Gerald Tegha; Charles S Chasela; Debbie Kamwendo; Charles M van der Horst; Lindsay H Allen Journal: Matern Child Nutr Date: 2017-08-29 Impact factor: 3.092
Authors: Nomathemba C Chandiwana; Matthew Chersich; W D François Venter; Godspower Akpomiemie; Andrew Hill; Bryony Simmons; Shahin Lockman; Celicia M Serenata; Lee Fairlie; Michelle A Moorhouse Journal: AIDS Date: 2021-02-02 Impact factor: 4.632